申请人:Hitgen Inc.
公开号:EP3919488A1
公开(公告)日:2021-12-08
The present application discloses an immunomodulator, and specifically discloses a compound depicted by formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The compound provided in the present application can bind effectively to STING and has a good agonistic action on STING protein, and exhibits a good inhibitory effect on multiple tumors. Thus, the compound provided in the present application serves as a STING agonist and can be used for treating various related conditions. The compound provided in the present invention shows a very promising prospect for application thereof in the preparation of a medicament for treating a disease associated with STING activity (in particular, a medicament for treating an inflammatory disease, an allergic disease, an autoimmune disease, an infectious disease, a cancer or a precancerous syndrome) and in the preparation of an immune adjuvant, providing a novel option for clinically screening and/or preparing drugs for diseases associated with STING activity.
本申请公开了一种免疫调节剂,具体公开了一种由式(I)描述的化合物,或其立体异构体,或其药学上可接受的盐。本申请提供的化合物能与 STING 有效结合,对 STING 蛋白有良好的激动作用,对多种肿瘤有良好的抑制作用。因此,本申请提供的化合物可作为 STING 激动剂,用于治疗各种相关疾病。本发明提供的化合物在制备治疗 STING 活性相关疾病的药物(尤其是治疗炎症性疾病、过敏性疾病、自身免疫性疾病、传染性疾病、癌症或癌前综合征的药物)和制备免疫佐剂方面具有非常广阔的应用前景,为临床筛选和/或制备治疗 STING 活性相关疾病的药物提供了一种新的选择。